SEPTInvestingStart Free

KYTX 10-Q: SEC filing

Kyverna Therapeutics

Filed with the SEC on · accession 0001193125-26-457043

KYTX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Kyverna Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The stock moved -1.8% by the first close after the filing.

Summary of the filing

Kyverna Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The filing includes details on loan agreements, license agreements, and equity incentive plans.

For details, click here →How to read a 10-Q →

Key details

LicensorKite Pharma, Inc.
LicensorNational Institutes of Health

How KYTX stock reacted

Close before

$5.12

Nov 11, 2026

First close after

-1.76%

$5.03

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for KYTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KYTX?

Click here

Frequently asked questions

What did KYTX file with the SEC on Nov 12, 2026?

KYTX filed a 10-Q (SEC filing). Kyverna Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, cash position, and ongoing clinical development activities. The filing includes details on loan agreements, license agreements, and equity incentive plans.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did KYTX stock react to this filing?

KYTX closed at $5.12 before the filing and $5.03 on Nov 12, 2026 (-1.76%).

Other KYTX SEC filings

Get alerts when KYTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
KYTX overviewKYTX analysisKYTX newsLatest SEC filings